Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Lung Neoplasms 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Wilms Tumor 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma, Ewing 2Sarcoma 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Carcinoma, Ovarian Epithelial 2Adenocarcinoma of Lung 2Adenocarcinoma Of Esophagus 2Vaginal Neoplasms 1Urethral Neoplasms 1Testicular Neoplasms 1Teratoma 1Rhabdomyosarcoma 1Rectal Neoplasms 1Radiation Injuries 1Radiation Fibrosis Syndrome 1Prostatic Neoplasms 1Postoperative Complications 1Ovarian Germ Cell Cancer 1Osteosarcoma 1

Interventions

Radiotherapy 9Vincristine 8Dactinomycin 8Cyclophosphamide 8Ifosfamide 6Radiation 5Filgrastim 5Doxorubicin 5Irinotecan 4sargramostim 3pegfilgrastim 2brostallicin 2Vinorelbine 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Granulocyte Colony-Stimulating Factor 2Biopsy 2trioctyl phosphine oxide 1perifosine 1lorvotuzumab mertansine 1irinotecan sucrosofate 1imetelstat 1exatecan 1etoposide phosphate 1X-Rays 1Trabectedin 1Topotecan 1Surgical Procedures, Operative 1Spinal Puncture 1Sentinel Lymph Node Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Rhabdomyosarcoma × Surgical Procedures, Operative × Clear all
NCT00075582 2021-11-19

Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Completed
390 enrolled 14 charts
Sarcoma

Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡